PTEN loss confers sensitivity to rapalogs in clear cell renal cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PTEN loss confers sensitivity to rapalogs in clear cell renal cell carcinoma

Published:2022-02-14 Issue:9 Volume:43 Page:2397-2409
ISSN:1671-4083
Container-title:Acta Pharmacologica Sinica
language:en
Short-container-title:Acta Pharmacol Sin

Author:

Liu Xiao-lian,Zhang Gui-ming,Huang Si-si,Shi Wen-hui,Ye Lin-xuan,Ren Zhong-lu,Zhang Jia-jie,Liu Shu-wen,Yu Le,Li Yi-lei

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.nature.com/articles/s41401-022-00862-1.pdf

Reference37 articles.

1. Hsieh JJ, Purdue MP, Signoretti S, Swanton C, Albiges L, Schmidinger M, et al. Renal cell carcinoma. Nat Rev Dis Prim. 2017;3:17009.

2. Xiao GF, Yan X, Chen Z, Zhang RJ, Liu TZ, Hu WL. Identification of a novel immune-related prognostic biomarker and small-molecule drugs in clear cell renal cell carcinoma (ccRCC) by a merged microarray-acquired dataset and TCGA database. Front Genet. 2020;11:810.

3. Dizman N, Philip EJ, Pal SK. Genomic profiling in renal cell carcinoma. Nat Rev Nephrol. 2020;16:435–51.

4. Hua H, Kong Q, Zhang H, Wang J, Luo T, Jiang Y. Targeting mTOR for cancer therapy. J Hematol Oncol. 2019;12:71.

5. Hudes G, Carducci M, Tomczak P, Dutcher J, Figlin R, Kapoor A, et al. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med. 2007;356:2271–81.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decoding PTEN regulation in clear cell renal cell carcinoma: Pathway for biomarker discovery and therapeutic insights;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. Molecular analysis of primary and metastatic sites in patients with renal cell carcinoma;Journal of Clinical Investigation;2024-05-30

3. Exploring the tumor microenvironment: Chemokine‐related genes and immunotherapy/chemotherapy response in clear‐cell renal cell carcinoma;Environmental Toxicology;2024-03-15

4. CircPTEN suppresses human clear cell renal carcinoma progression and resistance to mTOR inhibitors by targeting epigenetic modification;Drug Resistance Updates;2023-11

5. Renal Neoplasia Occurring in Patients With PTEN Hamartoma Tumor Syndrome;American Journal of Surgical Pathology;2023-06-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3